PROCTER & GAMBLE Co·4

Mar 11, 2:04 PM ET

Kempczinski Christopher J 4

4 · PROCTER & GAMBLE Co · Filed Mar 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Procter & Gamble Director Christopher Kempczinski Receives 201 RSUs

What Happened
Christopher J. Kempczinski, a director of Procter & Gamble Co. (PG), received a grant of 201 Restricted Stock Units (RSUs) on March 10, 2026. The award is reported at $0.00 per unit (standard for RSU grants); value will depend on P&G share price when units vest/convert. This was an equity compensation award (transaction code A), not a purchase or sale.

Key Details

  • Transaction date: 2026-03-10; filing date: 2026-03-11 (timely).
  • Grant: 201 RSUs at $0.00 per unit (reported acquisition amount $0).
  • Shares owned after transaction: not specified in the provided filing summary.
  • Footnotes: F1 — RSUs awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 — Total includes grant of dividend equivalents in the form of RSUs.
  • Filing appears timely (no late filing flag).

Context
RSUs are compensation awards that typically vest over time and convert into common shares (or cash equivalent) when vesting conditions are met. They represent future equity compensation rather than an immediate market purchase or sale, so they do not directly signal buying or selling sentiment. As a director-level award, this is part of routine executive/director compensation practices.

Insider Transaction Report

Form 4
Period: 2026-03-10
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-03-10+20111,251.481 total
Footnotes (2)
  • [F1]Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
  • [F2]Total includes grant of dividend equivalents in the form of Restricted Stock Units.
Signature
/s/ Wednesday Shipp, attorney-in-fact for Christopher Kempczinski|2026-03-11

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT